Skillman, NJ, United States of America

Danxi Li

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Danxi Li

Introduction

Danxi Li is a prominent inventor based in Skillman, NJ, known for his significant contributions to the field of biotechnology. With a total of 8 patents to his name, he has made remarkable advancements in the development of therapeutic antibodies.

Latest Patents

One of Danxi Li's latest patents involves antibodies that bind to IL-4 and/or IL-13 and their uses. This invention relates to novel humanized anti-IL-4 and IL-13 antibodies and fragments that specifically target these interleukins. The patent also includes bispecific antibodies that can treat or prevent IL-4 and/or IL-13 mediated diseases, such as allergic asthma and dermatitis. Another notable patent focuses on the uses of a dual V region antibody-like protein, which has potential applications in various therapeutic contexts.

Career Highlights

Danxi Li is currently employed at Sanofi, a global biopharmaceutical company. His work at Sanofi has allowed him to explore innovative solutions in the treatment of complex diseases. His expertise in antibody development has positioned him as a key player in the biotechnology sector.

Collaborations

Danxi Li has collaborated with notable colleagues, including Ercole Rao and Vincent Mikol. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Danxi Li's contributions to biotechnology through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…